A comprehensive de-identified multimodal oncology dataset (clinical, molecular and imaging records) licensed by Tempus AI to Pathos AI to train a foundational oncology model for AstraZeneca, three-year licence
data license fees of $200 million over a three-year period, including an upfront payment of $50 million total data licence fees over a three-year term
Dated 17 Apr 2025Source checked 27 Oct 2026Basis: stated
In the source's own words
“Pathos will pay Tempus data license fees of $200 million over a three-year period, including an upfront payment of $50 million payable on the Effective Date”
Where it was read
Also read from the same source
What it is about
Figures it counts in
- $190M per contractData products, sales that happened, per contract